https://doi.org/10.4081/reumatismo.2018.1070

Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
Submitted: 25 August 2017
Accepted: 3 November 2017
Published: 27 March 2018
Polymyalgia rheumatica, Classification, Diagnosis.
Abstract Views: 1972
PDF: 1520
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B.D. Nielsen
Department of Rheumatology and Department of Clinical Medicine, Aarhus University Hospital, Denmark.
B. Dasgupta
bhaskar.dasgupta@southend.nhs.uk
Rheumatology Department, Southend University Hospital, Westcliff-on-sea, United Kingdom.
Polymyalgia rheumatica is effectively treated with glucocorticoids. However, glucocorticoid treatment can cause numerous and potentially serious side effects. Therefore, lowest effective dose and shortest duration to control disease is aimed for and glucocorticoid-sparing treatments are needed. Nevertheless, development of treatment regimens in PMR has been hampered by the lack of reliable classification criteria and evidence-based outcome measures. In this editorial, we discuss the need for valid classification criteria in PMR, the strengths and limitations of the ACR/EULAR 2012 provisional classification criteria for PMR and the need of validation and possible refining of the criteria.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
B.D. Nielsen, Department of Rheumatology and Department of Clinical Medicine, Aarhus University Hospital
Department of Rheumatology and Department of Clinical Medicine, MD PhD fellow
B. Dasgupta, Rheumatology Department, Southend University Hospital, Westcliff-on-sea
Rheumatology Department, Professor

How to Cite

Nielsen, B., & Dasgupta, B. (2018). Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica. Reumatismo, 70(1), 1–9. https://doi.org/10.4081/reumatismo.2018.1070

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.